Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis
- 25 July 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Neuroimmune Pharmacology
- Vol. 8 (4), 888-899
- https://doi.org/10.1007/s11481-013-9489-x
Abstract
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with selective loss of upper and lower motor neurons. At sites of motor neuron injury, neuroinflammation is a prominent pathological finding and is characterized by microglial activation, astrogliosis, and infiltration of monocytes and T-cells. Both innate and adaptive immune responses actively influence disease progression in animal models and in ALS patients, and promote neuroprotection or neurotoxicity at different stages of disease. The early immune reaction to signals from injured motor neurons is to rescue and repair damaged tissue. As disease accelerates, a shift occurs from beneficial immune responses (involving M2 microglia and regulatory T-cells) to deleterious immune responses (involving M1 microglia and Th1 cells). In this review, we underscore the importance of immune-mediated mechanisms in the pathogenesis of ALS and discuss the alterations and distinct phenotypes of immune cells at the different stages of disease. The better we understand the dynamic changes that occur within the immune system over the course of disease, the better we will be able to develop effective therapeutic regimens in ALS.Keywords
This publication has 79 references indexed in Scilit:
- Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALSJCI Insight, 2012
- An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1Proceedings of the National Academy of Sciences of the United States of America, 2012
- Non-viral gene delivery of the GDNF, either alone or fused to the C-fragment of tetanus toxin protein, prolongs survival in a mouse ALS modelRestorative Neurology and Neuroscience, 2012
- Alterations of T cell subsets in ALS: a systemic immune activation?Acta Neurologica Scandinavica, 2011
- Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic miceProceedings of the National Academy of Sciences of the United States of America, 2009
- MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosisThe Journal of cell biology, 2007
- Mutant SOD1G93A microglia are more neurotoxic relative to wild‐type microgliaJournal of Neurochemistry, 2007
- Increased cytotoxic potential of microglia from ALS‐transgenic miceGlia, 2004
- Neuroprotective Effects of Glial Cell Line-Derived Neurotrophic Factor Mediated by an Adeno-Associated Virus Vector in a Transgenic Animal Model of Amyotrophic Lateral SclerosisJournal of Neuroscience, 2002
- Neuron-Specific Expression of Mutant Superoxide Dismutase 1 in Transgenic Mice Does Not Lead to Motor ImpairmentJournal of Neuroscience, 2001